• About us
• Contact

Advertisement

Product › Details

lipid nanoparticle technology (LNP technology)

	Next higher product group	lipid vector

Record changed: 2024-08-06

Advertisement

More documents for lipid nanoparticle technology (LNP technology)

• [1] Etherna N.V.. (7/10/24). "Press Release: Antonin (Tony) de Fougerolles Appointed as New Chair of Etherna". Niel....
• [2] Pantherna Therapeutics GmbH. (5/3/24). "Press Release: Company Update. Ansgar Santel Appointed as New CEO". Frankfurt a. M. & Hennigsdorf....
• [3] Pantherna Therapeutics GmbH / Wacker. (4/5/24). "Press Release: Pantherna and Wacker Intensify Collaboration in the Development and Production of mRNA Biopharmaceuticals". Munich & Hennigsdorf....
• [4] Bayer, Max [Fierce Biotech]. (11/6/23). "News: BioNTech Adds Bispecific Candidate, mRNA Delivery Startup as Cancer Work Takes Center Stage"....
• [5] Etherna N.V.. (10/17/23). "Press Release: mRNA/LNP Technology Platform Company Etherna Names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board". Niel....
• [6] Mana.bio. (10/10/23). "Press Release: Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate »Programmable Drug Delivery« for RNA and Gene Therapies". Tel Aviv....
• [7] Leon-Nanodrugs GmbH. (7/18/23). "Press Release: Leon-Nanodrugs Appoints Dr. Hans Frickel as Chief Executive Officer". Munich....
• [8] Ardena Holding N.V.. (7/4/23). "Press Release: Ardena and RiboPro Forge Strategic Alliance to Support the RNA Revolution with End-to-End Manufacturing of Advanced mRNA and LNP Solutions"....
• [9] Bayer AG. (6/5/23). "Press Release: Bayer Strengthens Gene Therapy Portfolio with Lipid Nanoparticle Technology from Acuitas Therapeutics [Not intended for U.S. and UK Media]". Berlin....
• [10] Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.